Tradestie Institutional Equity Comparison Engine

DCTH vs CNSY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DCTH Overall Edge

DCTH Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DCTH trades at N/M Forward P/E with 5.2% operating margin (+70.7% YoY revenue) versus CNSY at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro) against CNSY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner DCTH
DCTH N/M vs CNSY N/M Fwd P/E
Growth & Margin Winner DCTH
Op Margin 5.2% vs N/A ยท YoY +70.7% vs N/A
Momentum & Technical Winner DCTH
1Y +128.6% vs -79.5% ยท 52W Pos 80% vs 8%
Options & Structure Winner DCTH
BREAKOUT (43rd %ile IV) vs UNCLASSIFIED (N/A IV)
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap $743.8M
1M Return +39.77%
1Y Return +128.57%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0
CNSY US Equity
CNSY
Institutional Equity
$0.72
-24.24% 1D
Market Cap N/A
1M Return -57.65%
1Y Return -79.55%
Forward P/E N/M
Unified AI Score
47.6 / 100 HOLD
Tech 65.0 Fund 55.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DCTH +128.57% CNSY -79.55% Spread: +130.47 pp (DCTH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DCTH TTM Op. Margin: 5.2% CNSY TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DCTH vs CNSY. Trailing 12-month operating profitability (DCTH 5.2% vs CNSY N/A) and valuation multiples (DCTH N/M vs CNSY N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DCTH (8) vs CNSY (1)
Institutional Metric DCTH CNSY Criterion Row Winner
Market Capitalization Scale $743.8M N/A Larger Scale DCTH
Trailing P/E Ratio Valuation 133.6x N/M Lower Multiple DCTH
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +70.7% N/A Higher Growth DCTH
Operating Margin (TTM) Profitability 5.2% N/A Higher Margin DCTH
Net Profit Margin Profitability 6.0% N/A Higher Margin DCTH
Return on Equity (ROE) Capital Efficiency 5.4% N/A Higher ROE DCTH
52-Week Range Position Momentum 80% ($8โ€“$23) 8% ($0โ€“$4) Stronger Trend DCTH
Beta / 30D Volatility Risk Regime 1.63ฮฒ ยท 131% Vol 2.54ฮฒ ยท 228% Vol Lower Realized Risk DCTH
Unified Institutional Score Composite Signal 35.9 / 100 (SELL) 47.6 / 100 (HOLD) Higher Composite CNSY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DCTH vs CNSY Buy Guide
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CNSY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CNSY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DCTH nor CNSY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.